About Whiterabbit.ai
Whiterabbit.ai is a venture-backed artificial intelligence company based in Silicon Valley that specializes in transforming breast cancer screening through advanced AI technology. The company's mission is to make late-stage breast cancer a rarity by detecting it early through the power of AI, revolutionizing the screening paradigm by removing barriers to adoption and enhancing collaboration between artificial and human intelligence. Founded by executives with deep operational experience in radiology—having owned and operated 9 outpatient radiology sites—Whiterabbit brings a unique understanding of clinical workflows and constraints. This operational DNA informs their product development approach, ensuring solutions integrate seamlessly into existing clinical environments. The company's commercially available products, WRDensity and WRRisk, leverage a proprietary dataset spanning more than 2 million patients and 11 million datapoints. These AI-powered tools address critical challenges in breast imaging including mammographic density assessment and cancer risk stratification, helping to address the critical shortage of radiologists while improving clinical outcomes, optimizing patient experience, and reducing healthcare costs. Whiterabbit collaborates with leading academic and professional institutions including Washington University's Mallinckrodt Institute of Radiology, Stanford University, Guardant Health, and RadNet. The company's team comprises over 30-50 AI scientists, engineers, and healthcare professionals dedicated to advancing early detection and improving diagnostic accuracy in breast cancer care. Led by CEO Alexander Sardiña, MD, a physician with extensive experience in early detection, Whiterabbit continues to advance its mission with several patents pending and products in development.
Mission & Story
Mission
Whiterabbit's mission is to make late-stage breast cancer a rarity by detecting it early through the power of AI. We aim to revolutionize the screening paradigm by removing barriers to adoption and enhancing collaboration between artificial and human intelligence for better patient outcomes.
Founding Story
In the early days of the company, Whiterabbit owned and operated 9 outpatient radiology sites, developing a deep appreciation of clinical operations and constraints. This early operational experience helped the founders understand the needs and pain points of their direct customers and patients, informing their approach to developing AI solutions for breast cancer screening.
Clinical Focus
Medical conditions and clinical areas addressed by Whiterabbit.ai.
Who It Serves
Milestones & Awards
Recent Milestones
RadNet comprehensive partnership announced August 2022; American College of Radiology collaboration announced November 2023 to enable democratized access to AI; Longitudinal study presented at RSNA October 2022; Study launched September 2023 to evaluate AI impact on radiologists' performance
Key Partnerships
Social & Media
Latest Updates
Featured news
2y ago
Whiterabbit.ai Announces Call for Radiologists to Participate in Study to Evaluate the Impact of Artificial Intelligence on Radiologists’ Performance
2y ago
Longitudinal Study of AI in Breast Density to be presented at RSNA
3y ago
Bringing humans and AI together to improve mammography outcomes
3y ago
Company Details
- Headquarters
- Silicon Valley, CA, USA
- Employees
- 51-200
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 189 →
A2z Radiology Ai
AI platform that triages urgent abdomen-pelvis CT findings and prioritizes flagged studies in radiology worklists.
Adas3D Medical S.L
11-50 employees
Adas3D Medical develops medical imaging software that extracts key clinical information from cardiac MRI and CT scans for electrophysiologists. The software helps plan, guide, and monitor catheter ablation procedures by visualizing and quantifying fibrotic tissue in the heart.
AEYE Health
11-50 employees
AEYE Health provides FDA-cleared autonomous AI diagnostic screening for diabetic retinopathy and other eye diseases using retinal images. Their point-of-care solution enables primary care physicians to screen and diagnose patients instantly with portable or desktop cameras.
Agfa HealthCare N.V.
AGFA HealthCare provides enterprise imaging platforms that unify medical imaging across specialties. The company delivers PACS, vendor neutral archives, AI-powered workflow orchestration, and cloud-based imaging solutions to hospitals and healthcare systems worldwide.
AI4MedImaging Medical Solutions
AI4MedImaging provides AI-powered medical imaging solutions distributed through aycan Medical Systems in the Americas. Their flagship product, AI4CMR, is software as a medical device (SaMD) that automates the interpretation of cardiac magnetic resonance imaging using artificial intelligence.
Aidence
Aidence, now part of DeepHealth, develops AI-powered clinical applications for radiology and medical imaging. The company specializes in lung nodule detection, classification, and patient management solutions that empower radiologists and physicians in interpreting medical images.
Aidoc
growth · 350 employees
Aidoc empowers health systems to improve patient outcomes and operations with enterprise-grade healthcare AI.
Aikenist Technologies Pvt Ltd
21-100 employees
Aikenist Technologies is a MedTech company specializing in advanced AI-driven solutions for radiology imaging. Their offerings include an FDA-approved AI PACS and RIS with integrated viewer, appointment scheduling, billing modules, and AI tools for stroke, oncology, and neuro detection.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.